Type | Name | Gene Symbol | Clinical Significance | Chromosome | Start | Stop | Reference Allele | Alternate Allele | Review Status | Other IDs |
---|---|---|---|---|---|---|---|---|---|---|
(GRCh37) | ||||||||||
Duplication | NM_000059.4(BRCA2):c.1321dup (p.Thr441fs) | BRCA2 | Pathogenic | 13 | 32906935 | 32906936 | T | TA | reviewed by expert panel | Breast Cancer Information Core (BIC) (BRCA2):1549&base_change=ins A,ClinGen:CA011591 |
single nucleotide variant | NM_000059.4(BRCA2):c.1325C>A (p.Ser442Ter) | BRCA2 | Pathogenic | 13 | 32906940 | 32906940 | C | A | reviewed by expert panel | ClinGen:CA011601 |
Deletion | NM_000059.4(BRCA2):c.2834_2835del (p.Lys945fs) | BRCA2 | Pathogenic | 13 | 32911322 | 32911323 | TAA | T | reviewed by expert panel | Breast Cancer Information Core (BIC) (BRCA2):3062&base_change=del AA,ClinGen:CA016544 |
Deletion | NM_000059.4(BRCA2):c.2835del (p.Asp946fs) | BRCA2 | Pathogenic | 13 | 32911322 | 32911322 | TA | T | reviewed by expert panel | ClinGen:CA016557 |
Indel | NM_000059.4(BRCA2):c.1817_1819delinsTTT (p.Pro606_Lys607delinsLeuTer) | BRCA2 | Pathogenic/Likely pathogenic | 13 | 32907432 | 32907434 | CGA | TTT | criteria provided, multiple submitters, no conflicts | ClinGen:CA013422 |
Indel | NM_000059.4(BRCA2):c.3075_3076delinsTT (p.Lys1025_Lys1026delinsAsnTer) | BRCA2 | Pathogenic | 13 | 32911567 | 32911568 | GA | TT | reviewed by expert panel | ClinGen:CA017179 |
Deletion | NM_000059.4(BRCA2):c.5195del (p.Leu1732fs) | BRCA2 | Pathogenic | 13 | 32913687 | 32913687 | CT | C | reviewed by expert panel | ClinGen:CA021647 |
Duplication | NM_000059.4(BRCA2):c.5364dup (p.Lys1789fs) | BRCA2 | Pathogenic | 13 | 32913854 | 32913855 | T | TC | reviewed by expert panel | ClinGen:CA022147 |
Deletion | NM_007294.3(BRCA1):c.135-?_441+?del | BRCA1 | Pathogenic | 17 | 41256139 | 41258550 | na | na | criteria provided, multiple submitters, no conflicts | - |
Deletion | NM_007294.3(BRCA1):c.4186-?_4675+?del | BRCA1 | Pathogenic | 17 | 41226348 | 41234592 | na | na | criteria provided, multiple submitters, no conflicts | - |